Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5562 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 38 39 40 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
BRAIN–Germany (govt): grant, 201206– funding from BMBF for up to 9y as partner + coordinator of NatLifE 2020 alliance 2012-06-01
CryoTherapeutics–High-Tech Gründerfonds: investment, 201206–201303 financing round Series A totalling €3m incl investor HTGF in 1st closing June 2012 2012-06-01
CryoTherapeutics–SEVERAL: investment, 201206–201303 financing round Series A €3m NRW.Bank + HTGF + Rainer Christine + Getz Brothers + PVP 2012-06-01
Roche–AC Immune: therapeutic antibodies, 201206– license excl for anti-Tau program for Alzheimer’s disease to Genentech 2012-06-01
Bayer–Covance: clinical research services, 201205– supply strategic alliance incl phase 2–4 studies + central lab services for Bayer HealthCare 2012-05-30
AudioCure Pharma–High-Tech Gründerfonds: investment, 201205 seed financing from HTGF + business angel Dr Schumacher 2012-05-29
AudioCure Pharma–SEVERAL: investment, 201205 seed financing from High-Tech Gründersfonds + business angel Dr Schumacher 2012-05-29
Agilent–Prolab GmbH: mass spectrometer, –201205 collab co-development of integrated AACE LC/MS System for dried blood-spot analysis 2012-05-21
TU Munich–Nonlinear Dynamics: mass spectrometry s/w, 201205 supply existent use of Progenesis LC-MS s/w by Prof Küster 2012-05-21
EQT–Agilent: investment, 201205–201206 acquisition of Dako for $2.2b in cash on a debt-free basis 2012-05-17
Apeptico–SEVERAL: investment, 201205 financing round Series C €2m from BioScience Venture Group + V+ Fonds + private investors 2012-05-16
BioPlanta–Vita 34: investment, 201205 acquisition in shares with 380k new shares issued to BioPlanta owner + founder André Gerth 2012-05-16
Evotec–Agilent: mass spectrometer, 201205 supply 6460 Triple Quadrupole instrumentation to Hamburg facility 2012-05-16
Evotec–Agilent: mass spectrometer, 201205 supply multiple RapidFire High-throughput MS systems to Hamburg facility 2012-05-16
Cellzome–GSK: investment, 201205 acquisition remaining 80% for £61m ($99m) in cash 2012-05-15
Genome Diagnostics–Qiagen: PCR technology, 201205– distribution rights ww non-excl for Qiagen LongRange PCR kit together with SBTexcellerator reagents 2012-05-15
Ono Pharmaceutical–Coral BioNet: Affilin therapeutics, 201205– collab discovery + developm Affilin molecules against Ono targets with Scil Proteins 2012-05-15
T-Cell Europe–High-Tech Gründerfonds: investment, 201205 1st financing round totalling €1.45m incl HTGF 2012-05-15
T-Cell Europe–SEVERAL: investment, 201205 1st financing round €1.45m from HTGF + Constantin Bastian Leander Venture Capital + ILB 2012-05-15
Algiax Pharmaceuticals–High-Tech Gründerfonds: investment, 201205 financing round totalling €4.3m incl HTGF + private investors + KfW 2012-05-14
Algiax Pharmaceuticals–SEVERAL: investment, 201205 financing round €4.3m from HTGF + private investors + KfW 2012-05-14
Ecopetrol–Bruker Corp: mass spectrometer, 201205– supply purchase $2.5m 15 Tesla solariX FTMS system by Instituto Colombiano Petróleo (ICP) 2012-05-14
Waters–Biocrates: AbsoluteIDQ Kits, 201205– collab Waters Xevo TQ MS editions of established AbsoluteIDQ p180 + p150 kits 2012-05-14
Fresenius–SEVERAL: investment, 201205 capital increase €1b placement of 13.8m new ordinary shares €73.5/share 2012-05-11
Baliopharm–Apo GbR: therapeutic antibody, 201205– ww excl license for bi-specific therapeutic antibody Novotarg 2012-05-09
Evotec–4-Antibody: antibody drug discovery, 201205– collab integration of output from Rectrocyte Display technology into Ab drug discovery services 2012-05-09
Sophia Genetics–SEVERAL: investment, 201205 seed funding CHF840k from private investors 2012-05-08
Intercell–Bellevue: credit, 201205– secured 6-year loan €20m with variable interest rate >=10.9% + sales royalties from BB Biotech 2012-05-07
Intercell–Bellevue: investment, 201205 acquisition €5m 1.962m shares €2.55/share as part of private placement w institutional investors 2012-05-07
AmniSure–Qiagen: investment, 201205 acquisition €na 2012-05-03
United States (govt)–Evotec: compound management, 201205– supply compound management services €7.7m for 5y to US EPA by Evotec San Francisco 2012-05-03
Mondobiotech–BioPharma Invest: investment, 201205 existent BioPharma Invest AG is main shareholder 2012-05-02
Novaliq–Hopp Group: investment, 201205 financing round €3.9m from Dievini Hopp BioTech Holding GmbH & Co KG 2012-05-02
Valeant–Gentium: defibrotide, 201205– distribution excl for 10 years in Central + Eastern European countries by PharmSwiss SA 2012-05-02
Abionic–SEVERAL: investment, 201205 financing round Series A CHF3.5m from local VCs + business angels 2012-05-01
Bayer–Two Blades Foundation: TAL Code technology, 201205– non-excl commercial license €na to Bayer CropScience commercial use in certain crop plants 2012-05-01
BF Holding–MC Services: public relations, 201205– service public + investor relations for MagForce AG 2012-05-01
Roche–Dako: molecular companion diagnostics, 201205– collab regulatory submission HercepTest + HER2 FISH pharmDx for trastuzumab-DM1 Genentech 2012-05-01
Two Blades Foundation–Univ Halle: TAL Code technology, 201205 excl license for commercial use in plants existent 2012-05-01
Cardinal Health–Qiagen: molecular diagnostics, 201204– distribution of Qiagen systems + kits to smaller + mid-sized US hospitals by Cardinal Health 2012-04-30
Gen-Probe–Hologic: investment, 201204–201208 acquisition $3.8b in cash $82.75/share 2012-04-30
Quotient Bioresearch–Biotrend: sample labelling services, 201204– collab supply of Iodine-125 labelling services by Anawa Trading SA 2012-04-30
Analytical Perspectives of North Carolina–SGS: investment, 201204 acquisition 2012-04-27
Omega Scientific–Ionicon: mass spectrometer, 201204– distribution + support of Ioncion PTR-MS instruments by Omega in Malaysia 2012-04-27
Omega Scientific–Ionicon: mass spectrometer, 201204– distribution + support of Ioncion PTR-MS instruments by Omega in Singapore 2012-04-27
Omega Scientific–Ionicon: mass spectrometer, 201204– distribution + support of Ioncion PTR-MS instruments by Omega in Thailand 2012-04-27
Active Biotech–Evotec: drug discovery services, 201204– service €na expansion medicinal chemistry services drug optimisation 2012-04-26
Futalis–High-Tech Gründerfonds: investment, 201204 seed financing from HTGF 2012-04-26
Innovacell–SEVERAL: investment, 201204– capital increase €8.3m in two tranches 2012-04-26
Rhön-Klinikum–Fresenius: investment, 201204–201206 NOT REALISED cash tender offer €3.1b €22.5/share OFFER FAILED 2012-04-26
JnJ–Artes Biotechnology: cell line development, 201204– collab developm + supply of Hansenula cell lines to Crucell for two vaccines 2012-04-24
ConoGenetix–Bavaria (govt): investment, 201204 financing round Series A totalling €1.5m incl returning investor BioM AG 2012-04-23
ConoGenetix–Mey Capital Matrix: investment, 201204 financing round Series A totalling €1.5m incl lead investor Mey Capital Matrix GmbH 2012-04-23
ConoGenetix–SEVERAL: investment, 201204 financing round Series A €1.5m lead investor Mey Capital Matrix + co-investor BioM AG 2012-04-23
AJ Roboscreen–Analytik Jena: investment, 201204 acquisition of remaining shares with resulting 100% ownership by Analytik Jena AG 2012-04-20
4SC–Crelux: drug discovery services, 201204– strategic alliance offering integrated drug discovery services by 4SC Discovery + Crelux 2012-04-18
KonTEM–High-Tech Gründerfonds: investment, 201204 investment by HTGF 2012-04-17
Oncgnostics–High-Tech Gründerfonds: investment, 201204 seed funding from HTGF + STIFT 2012-04-16
Oncgnostics–SEVERAL: investment, 201204 seed funding from HTGF + STIFT 2012-04-16
Oncgnostics–Thuringia (govt): investment, 201204 seed funding from HTGF + STIFT 2012-04-16
Bayer–KWS: plant breeding, 201204– collab co-developm breeding of herbicide-resistant varieties for weed control system Bayer CropScience 2012-04-12
Aleva Neurotherapeutics–SEVERAL: investment, 201204 financing round Series B CHF4m lead + new investor Banexi Ventures Partners 2012-04-10
Bipharma–Biofrontera: 5-aminolevulinic acid, 201204– excl marketing + distribution of Ameluz in Benelux by Bipharma NV 2012-04-04
ZIM Plant Technology–High-Tech Gründerfonds: investment, 201204 investment by HTGF 2012-04-04
Henkel–4SC: compound screening, 201204– collab computerised screening to identify laundry detergent ingredients 4SC Discovery GmbH 2012-04-02
Bayer–Piramal: investment, 201204 acquisition of molecular imaging business from Bayer Healthcare 2012-04-01
Merck (DE)–Kadimastem: drug discovery services, 201204– supply 5y framework agreem for use of functional tissues for MS drug screening 2012-04-01
Thermo Fisher–Peak Scientific: gas generator, 201203 collab Genius 1022 nitrogen generator specifically developed for Thermo’s Q Exactive system 2012-03-30
Allergan–Biofrontera: 5-aminolevulinic acid, 201203– excl marketing + distribution of Ameluz in Spain TERMINATED 11/14 2012-03-29
Altona Diagnostics–EU (govt): grant, 201203– EFRE funding €4.63m for ADT + BNI for €9m joint tropical disease project 2012-03-29
Altona Diagnostics–Hamburg (govt): grant, 201203– funding €400k for ADT + BNI for €9m joint tropical disease project 2012-03-29
Altona Diagnostics–Leibniz-Gemeinschaft: molecular diagnostics, 201203– collab tropical diasease biobank + developm of respective tests ADT + BNI 2012-03-29
Leibniz-Gemeinschaft–EU (govt): grant, 201203– EFRE funding €4.63m for ADT + BNI for €9m joint tropical disease project 2012-03-29
Leibniz-Gemeinschaft–Hamburg (govt): grant, 201203– funding €400k for ADT + BNI for €9m joint tropical disease project 2012-03-29
Protagen–Kairos GmbH: biobank management s/w, 201203– collab marketing + sales by Protagen 2012-03-29
GATC Biotech–Hamilton: lab automation equipment, 201203 supply existent fleet of Hamilton robotics at GATC Cologence Sequencing Centre 2012-03-28
Promethera–Boehringer: investment, 201203 financing round Series B totalling €17m incl new investor Boehringer Ingelheim Venture Fund 2012-03-28
Promethera–SEVERAL: investment, 201203 financing round Series B €17m incl new investors Boehringer + Shire + Mitsui 2012-03-28
Univ Oslo–Thermo Fisher: mass spectrometer, 201203 supply Q-Exactive Orbitrap MS to Bioanalytics@UiO for proteomics + metabolomics applications 2012-03-28
Bayer–Tsinghua Univ: drug discovery, 201203– collab expansion over next 3 years 2012-03-27
Thermo Fisher–Greenough: public relations, 201203 service existent Thermo Fisher listed as client on Greenough web site 2012-03-27
Chugai–Genedata: bioinformatics, 201203– license multi-year extension for Genedata Expressionist s/w 2012-03-26
ImaginAb–Novartis: investment, 201203 financing round Series A totalling $12.5m incl lead investor Novartis Venture Funds 2012-03-26
ImaginAb–SEVERAL: investment, 201203 financing round Series A $12.5m led by Novartis Venture Funds 2012-03-26
Cytos Biotechnology–SEVERAL: investment, 201203 financing round of up to CHF37m in equity and debt led by venBio 2012-03-21
Evonik–Leibniz-Gemeinschaft: catalysts, 201203– collab extension long-term catalysis research with Leibniz Institute for Catalysis (LIKAT) 2012-03-21
Shimadzu–Sony: MALDI targets, 201203– collab extension developm application-specific + barcoded disposable MALDI targets by Kratos + Sony DADC 2012-03-21
Boehringer–Ablynx: Nanobodies, 201203–201409 collab extenstion 2y discovery up to 10 Nanobodies excl ww rights dev + manuf + marketing 2012-03-20
High-Tech Gründerfonds–Evonik: investment, 201203 investment of €2.5m in High-Tech Gründerfonds II 2012-03-20
CCS Cell Culture Service–ChromoTek: Chromobody cell lines, 201203– collab service + distribution + co-marketing by CCS 2012-03-15
CEVA–Minapharm: cell line, 201203– license €na multi-product to ProBioGen’s AGE1.CR avian cell line for production of viral animal vaccines 2012-03-15
EuroEPINOMICS project–Cartagenia: functional genomics, 201203– collab partner in RES project providing Cartagenia BENCH platform 2012-03-14
Baliopharm–Germany (govt): grant, 201203– BMBF grant €1.3m for pre-clincial + clinical development of Atrosab 2012-03-13
Univ Münster–Thermo Fisher: mass spectrometer, 201203 supply existent iCAP Q ICP-MS systems Karst group is early customer 2012-03-12
Bayer–Thompson Agronomics: soybeans, 201203 acquisition €na germplams assets of soybean breeding division ProSoy Genetics by Bayer CropScience 2012-03-09
Instituto Politécnico Nacional–Bruker Corp: mass spectrometer, 201203 supply purchase Autoflex Speed MALDI TOF/TOF mass spectrometer by CNMN 2012-03-06
Instituto Politécnico Nacional–Bruker Corp: mass spectrometer, 201203 supply purchase MicrOTOF-Q II ESI-Qq-TOF mass spectrometer by CNMN 2012-03-06
Maine Manufacturing–General Electric: protein microarray technology, 201203– acquisition excl right to commercialise FAST Protein Array product line 2012-03-06
Affimed–SAW Instruments: sam Biosensor, 201203 supply existent Affimed is sam biosensor customer of SAW 2012-03-05
Biofrontera–Maschmeyer Group: investment, 201203 as part of €11.5m capital increase Alstin acquires resulting share of 12.5% 2012-03-02
next pagenext page 1 2 3 ... 38 39 40 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top